Skip to main content

Table 2 Transmission of sCJD and iCJD with variable PrPSc allotypes into tg66 and tgRM mice overexpressing human PrPC-M129

From: Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes

 

tg66

tgRM

Case #a

Subtypeb

PrPSc-M129c

DPId

Clin/totale

DPId

Clin/totale

Control

MM1

100

187 ± 13

9/9

211 ± 11

8/8

3

MV1 + 2C

100 ± 0****

196 ± 19

8/8

218 ± 13

7/8

4

MV1 + 2C

34 ± 5

>  611

0/7

>  651

0/6

9 (CC)

MV2K + 2C

82 ± 8**

>  502

0/5

>  662

0/7

9 (CbC)

MV2K + 2C

33 ± 8

488 ± 17

5/5

519 ± 26

2/4

12

MV2K + 2C

29 ± 20

497 ± 132

2/5

471

1/7

19 (iCJD)

MV2K

66 ± 4***

184 ± 2

3/3

214 ± 9

7/7

10

MV2K

43 ± 2

407 ± 36

7/7

503 ± 54

5/6

20 (iCJD)

MV2K

39 ± 6

482 ± 34

2/7

373

1/5

7

MV2K

38 ± 18

398 ± 13

6/6

448 ± 18

4/5

18 (iCJD)

MV2K

36 ± 5

238 ± 17

5/8

296 ± 46

4/7

11

MV2C

85 ± 1

401 ± 21

2/8

>  790

0/8

  1. aNeuropathological subtype of cases originally described in [28]. All cases are sCJD except where noted as iCJD. CB cerebellar cortex, CC cerebral cortex
  2. bCases originally described in [28]. MV2K = CJD subtype MV2 with kuru (K) plaques; 2C = Type 2 PrPSc in the cortex
  3. cPercentage of PrPSc in the inoculum which is PrPSc-M129 shown as mean + standard deviation. Data adapted from [28]. **** p = 0.0001 versus case 4 by unpaired student’s t-test; ***p = 0.02 versus case 10, 0.007 versus case 20, 0.009 versus case 7, and 0.003 versus case 18 using Tukey’s multiple comparisons test; ** p = 0.01 versus case 9 (CbC) and 12 using Tukey’s multiple comparisons test
  4. dDPI = mean days post-infection + standard deviation
  5. eNumber of mice with clinical disease over total number of mice inoculated. Intercurrent deaths are not included